Skip to main content
. 2022 Feb 2;30(4):1628–1644. doi: 10.1016/j.ymthe.2022.01.039

Figure 8.

Figure 8

Gene profiling in LuCaP35CR tumors receiving the combination treatment

(A) RNA-seq analyses were performed using tumor samples from the LuCaP35CR study (at the end of the experiment). The Venn diagram for high-T-repressed genes, palbociclib-repressed genes, and the combination treatment-repressed genes is shown. (B) Heatmap view for the combination treatment-repressed genes in all tumor samples is shown. (C) GSEA for the downregulated genes by single treatments versus the combination treatment is shown. (D) Box plots for the change of expression of E2F target genes or Myc target genes in these samples are shown. (E and F) Heatmap view for E2Fs and E2F target genes (E) or MYC and its coregulator genes and a panel of Myc target genes (F) is shown.